 | By Schonfeld & Associates, Inc. According to a newly released study from Schonfeld & Associates, Inc., R&D Ratios & Budgets, the pharmaceutical industry continued to be the biggest R&D investor in fiscal 2021 with budgets of drug companies increasing by 24% to $168...
|
 | By Schonfeld & Associates, Inc. According to a newly released study from Schonfeld & Associates, Inc., R&D Ratios & Budgets, now in its 45th annual edition, the pharmaceutical industry continued to be the biggest R&D investor in fiscal 2020 with budgets of drug...
|
